Professor Simon Skene
Prof Skene has over 20 years’ experience as a medical statistician in teaching and research, including the design and analysis of studies investigating medicinal products, advanced therapies, diagnostic accuracy and surgery. His PhD focused on the analysis of very small samples of repeated measurements, addressing small sample issues in longitudinal analysis. He is a Fellow of the Royal Statistical Society and has consultancy experience in the pharmaceutical industry.
As Head of Statistics at the UCL Comprehensive Clinical Trials Unit, he provided leadership and statistical oversight on UK trials coordinated by the unit across phases I-III in multiple therapeutic areas including hepatology and gastroenterology, ophthalmology, neurology and surgery.
Prof Skene's appointment at University of Surrey combines the role of Director of the Clinical Trials Unit (CTU) and Clinical Research Facility (CRF) with leadership in statistics to support decision based practice in medicine. He is additionally Head of Department of Clinical and Experimental Medicine which brings together the CTU, CRF and Surrey Sleep Research Centre (SSRC) with complementary sections comprising Research Design Service - South East (RDS SE; Surrey Hub), Surrey Health Economics Centre (SHEC), Clinical Medicine and Statistical Multi-Omics. The department is dedicated to academic excellence in education and the delivery of clinical research in health and disease.
View Prof Skene's academic profile here.
Dr Hana Hassanin
Dr Hassanin qualified in medicine and surgery (MBBS) in 2000 and subsequently received a Doctorate of Medicine in Oncology and Immunotherapy in 2008 from Heidelberg University at the National Centre for Tumours in Germany with special interest in pancreatic adenocarcinoma. She has also obtained a PGDip in Diabetes from Cardiff University in 2011.
Dr Hassanin has more than 10 years experience in clinical trials. She has acted as Principal Investigator for over forty studies and has been Chief Investigator for a number of studies across different phases I, II, III and IV and various therapeutic areas such as Oncology, Diabetes, Cardiovascular (Hypertension and Hypercholesterolemia), Osteoporosis, Osteoarthritis, Insomnia, Benign Prostate Hypertrophy, respiratory diseases (COPD and Asthma), Immunology/vaccines, Urology ( Overactive bladder) and gastrointestinal diseases (IBS, constipation).
In March 2016, Dr Hassanin received a recognition award for broadening the understanding of clinical trials. She has received this recognition in the international educational event (Aware For All) organised by CISCRP, the Centre for Information and Study on Clinical Research Participation.
Before Joining Surrey CRC, Dr Hassanin was the UK Medical Operations Manager and was managing the medical team/conduction of clinical trials of eight dedicated clinical research centres (DCR) in the UK. She also worked as the Diabetes Regional Medical Advisor for the south east of England covering Kent, Surrey and Sussex.
Kathryn joined Surrey CRC in May 2016. Prior to this Kathryn worked in the QA team at The Pirbright Institute and as an Analyst for Thames Water.
Kathryn obtained her degree in Natural Science (Chemistry and Biology) from Durham University in 2011, and is a member of the UKCRF QA Workstream and the RQA.